6Jacoby GA, Sutton L. Properties of plasmids responsible for production of extended-spectrum beta-lactamases[J]. Antimicrob Agents Chemother, 1991, 35(1):164-169. 被引量：1
4Murray PR , Baron EJ, Pfaller MA, et al. Manual of Clinical microbiology 7th ed. American society for microbiology, Washington, D.C.1999, 262-560. 被引量：1
5National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. 12th inform suppl. M2-A7 and M7-A5.National Committee for Clinical Laboratory Standards, Wayne, pa, 2002, 42-49. 被引量：1
6Naumiuk L, Samer A, Dziemaszkiewicz E. Cefepime in vitro activity against derepressed extended-spectrum β-lactamase(ESBL)-producing and non-ESBL-producing Enterobacter cloacae by a disc diffusion method. J Antimicrob Chemother, 2001,48:321-322. 被引量：1
7Empey KM, Rapp RP, Evans ME.The effect of an antimicrobial formulary change on hospital resistance patterns. Pharmacotherapy, 2002,22:81-87. 被引量：1
8Pfaller, MA, Jones, RN, Doern, GV, et al. Bacterial pathogens isolated from patients with bloodstream infection: frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Cana 被引量：1
9Giamarellou H Fourth generation cephalosporins in the antimicrobial chemotherapy of surgical infectionsJ Chemother, 1999,11:486-493. 被引量：1
10Murthy SK, Balch AL, Smith RP, etal. Oropharyngeal and fecal carriage of Pseudomonas aeruginosa in hospital patients[J]. JClin Microbiol, 1989, 27(1):35-40 被引量：1
